TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.53
-0.20 (-2.29%)
Jul 21, 2026, 12:22 PM EDT - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.11 million as of July 21, 2026. Its market cap has decreased by -2.18% in one year.
Market Cap
8.11M
Enterprise Value
-4.82M
1-Year Change
-2.18%
Ranking
Category
Stock Price
$8.53
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.11M, a decrease of -83.07%. That is a compound annual growth rate of -29.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 8.11M | 29.43% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 9.25M |
| Immuron | 9.12M |
| Curis | 8.81M |
| MetaVia | 8.68M |
| Bolt Biotherapeutics | 8.60M |
| Aspire Biopharma Holdings | 8.52M |
| Quoin Pharmaceuticals | 8.46M |
| Aprea Therapeutics | 8.28M |